Sage Therapeutics, Inc. (SAGE) came out with a quarterly loss of $1.01 per share versus the Zacks Consensus Estimate of a loss of$0.99. This compares to loss of $1.80 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -2.02$1.45 per share when it actually produced a loss of $1.56, delivering a surprise of -7.59%.Over the last four quarters, the company has ...